Dr Ananth Nayak


Dr Ananth U Nayak MBBS; MRCP UK (Endocrinology); FRCP(Edin.); PGCE (Med Ed)

Year qualified: 2001

GMC: 6046165

Languages spoken: English, Kannada, Hindi, Konkani


Dr Nayak joined the team at University Hospital of North Midlands NHS Trust in 2013 as Consultant Physician in Endocrinology, Diabetes and General Medicine, having undertaken the higher specialist training programme as Specialist Registrar, including over 2 years of Clinical Research Fellowship in the West Midlands region. He obtained CCT and post nominal MRCP (Endocrinology & Diabetes) during his training. Soon after joining the Trust he led by example in developing innovative ways of running the joint antenatal diabetes clinics; improving efficiency and patient satisfaction. Dr Nayak is an ARSAC certified Endocrine Consultant and has revamped the Radioactive-iodine service for benign thyroid disease in the Trust. He has been instrumental in expanding the regional Insulin pump services and in incorporating innovative technology in effective diabetes management. He also actively collaborates with colleagues to support the diabetes renal service research and in designing novel pathways for managing endocrinopathies in conjunction with other specialities. The clinical research and service development projects undertaken by Dr Nayak have been recognised nationally and internationally with numerous peer review publications in high impact Diabetes and Endocrine journals. He is also involved with undergraduate Keele medical students and speciality training for post-gradute medical education toward supporting trainee doctors.


  • Diabetes Mellitus (type 1 and type 2 diabetes)
  • Thyroid and Parathyroid disorders
  • Adrenal and Pituitary disease
  • Metabolic disorders related to Calcium and Sodium


  • General Medical Council – Specialist Register
  • Royal College of Physicians
  • Society for Endocrinology
  • British Thyroid Association
  • British Thyroid Foundation


Original articles and review articles

  1. Exenatide therapy in insulin treated type 2 diabetes and obesity. QJM 2010; 103:687-694
  2. Evidence for consistency in the glycation gap in diabetes. Diab Care 2011;34:1712-6.
  3. The association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care 2013;36:3247-3253
  4. Hemoglobin A1c in early postpartum screening of women with gestational diabetes. World J Diabetes 2013;4:76-81.
  5. A method to validate the accuracy of a centralised district diabetes register. Pract Diab Int 2013;30:224-228
  6. Challenges of emerging adulthood-transition from paediatric to adult diabetes. World J Diabetes. 2014 Oct 15;5:630-5
  7. The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study. Diabet Med. 2014;31:403-11
  8. Can a baseline morning cortisol predict outcome of short Synacthen test in an endocrine unit in an outpatient setting. Clin Endocrinol (Oxf). 2015 Feb;82:309-11
  9. Too pushed to Discharge? – Hyponatraemia and its impact in hospitalised patients. Int J Endocrinol Metab Disord 2016;2(4)

Case reports

  1. A rare clinical sign need not always have a rare cause. BMJ 2009; 338:b1997
  2. An unusual cause for deterioration of glycaemia in diabetes. Pract Diab Int 2011;28:163
  3. Medical image. Pneumomediastinum – an unusual complication of diabetic ketoacidosis. N Z Med J 2013;126:97-98
  4. Splenic abscess as a potential initial manifestation of quiescent infective endocarditis in a patient with bronchopneumonia. BMJ Case Rep. 2015 Jan 5;2015
  5. Thymic hyperplasia and its spontaneous resolution with treatment of Graves’ hyperthyroidism. BMJ Case Reports 2016; doi:10.1136/bcr-2016-215285